Siemens Healthineers AG (OTCMKTS:SMMNY) Given Consensus Rating of “Strong Buy” by Brokerages

Shares of Siemens Healthineers AG (OTCMKTS:SMMNY) have received an average recommendation of “Strong Buy” from the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, one has given a buy recommendation and four have assigned a strong buy recommendation to the company.

A number of analysts recently weighed in on the stock. HSBC raised shares of Siemens Healthineers to a “buy” rating in a research note on Friday, April 25th. DZ Bank upgraded Siemens Healthineers from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 16th. Finally, Hsbc Global Res upgraded Siemens Healthineers from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 25th.

Siemens Healthineers Price Performance

Shares of Siemens Healthineers stock opened at $26.58 on Friday. The company’s fifty day moving average price is $26.48 and its two-hundred day moving average price is $27.16. Siemens Healthineers has a 52-week low of $23.28 and a 52-week high of $30.19.

Siemens Healthineers Company Profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.